Skip to content

TRYANCA

Absorbed by ANGLOPHARMA on 06-03-2015 KBO/BCE: BE 0451.398.903 subsidiary of Anglopharma

Mandates through the years

2 names

Director

Director
Earliermandate already running before its first mentionend not dated
Mandates as a list
    • Director, from before 15-02-2012, last mentioned in 2012
    • Director, from before 15-02-2012, last mentioned in 2012

Control

Parent
Equity €504,483
Profit €15,526 in 2026 (loss €83,090 in 2025)
Checked score
100%
This company
TRYANCA
Equity €449,342
Profit €7,295 in 2013

Capital

Capital
€379,587
Source
2013 annual accounts

Articles of association

deed of 21-10-2014 (in Dutch)
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 February to 31 January
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Wednesday of July at 14:00

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 06-03-2015 ↗
  • all shares

Office holders in the KBO →

Next steps